EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Up‐regulation of HOXA ‐ AS2 and MEG3 long non‐coding RNAs acts as a potential peripheral biomarker for bipolar disorder

Maryam Hosseini, Mohammad Javad Mokhtari iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.70150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Maryam Hosseini und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Zarghan Branch, Islamic Azad University, Zarghan, Iran. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Bipolar Disorder, Biomarkers. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bipolar disorder (BD) is a psychiatric condition that is frequently misdiagnosed and linked to inadequate treatment. Long non‐coding RNAs (lncRNAs) have lately gained recognition as crucial genetic elements and are now regarded as regulatory mechanisms in the neurological system. Our objective was to measure the quantities of HOXA‐AS2 and MEG3 ncRNA transcripts. HOXA‐AS2 and MEG3 ncRNA levels were checked in the peripheral blood of 50 type I BD and 50 control samples by real‐time PCR. Furthermore, we conducted ROC curve analysis and correlation analysis to examine the association between gene expression and specific clinical characteristics in instances with BD. Additionally, a computational study was performed to investigate the binding sites of miRNAs on the HOXA‐AS2 and MEG3 lncRNAs. BD subjects showed a significant increase in the expression of HOXA‐AS2 and MEG3 compared to controls. The lncRNAs HOXA‐AS2 and MEG3 have an area under the ROC curve (AUC) values of 0.70 and 0.71, respectively. There was a significant correlation between the expression levels of ncRNAs HOXA‐AS2 and MEG3 in the peripheral blood of patients with BD and occupation scores. The data presented indicate a potential correlation between the expression of HOXA‐AS2 and MEG3 lncRNAs with an elevated risk of BD. Furthermore, these lncRNAs may be linked to several molecular pathways. Our findings indicate that the amounts of lncRNAs HOXA‐AS2 and MEG3 in transcripts might be a promising potential biomarker for patients with BD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingBipolar DisorderBiomarkersHumansFemaleMaleAdultROC CurveUp-RegulationCase-Control StudiesMiddle AgedMicroRNAsGene Expression Regulation

Stichwörter der Autor:innen

BDLncRNAbiomarkergene expressionreal‐time PCR

Substanzen

RNA, Long NoncodingMEG3 non-coding RNA, humanBiomarkerslong noncoding RNA HOXA-AS2, humanMicroRNAs

Autor:innen und Institutionen

  • Department of Biology, Zarghan Branch, Islamic Azad University, Zarghan, Iran.

ORCID-Profile: Mohammad Javad Mokhtari

Zitieren

APA

Hosseini, M., & Mokhtari, M. J. (2024). Up‐regulation of HOXA ‐ AS2 and MEG3 long non‐coding RNAs acts as a potential peripheral biomarker for bipolar disorder. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70150

Vancouver

Hosseini M, Mokhtari MJ. Up‐regulation of HOXA ‐ AS2 and MEG3 long non‐coding RNAs acts as a potential peripheral biomarker for bipolar disorder. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70150

BibTeX
@article{Hosseini2024,
  author = {Hosseini, Maryam and Mokhtari, Mohammad Javad},
  title = {Up‐regulation of HOXA ‐ AS2 and MEG3 long non‐coding RNAs acts as a potential peripheral biomarker for bipolar disorder},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.70150}
}
Kostenlos starten →